Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 3 to 7, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Many Oncology Patients Are Lonely During COVID-19
FRIDAY, May 7, 2021 (HealthDay News) — More than half of oncology patients are experiencing loneliness during the COVID-19 pandemic, and they report higher symptom severity scores for all symptoms evaluated, according to a study published online April 27 in Cancer.
Read Full Text
Poll Finds Many Parents Hesitant to Get Younger Children Vaccinated
FRIDAY, May 7, 2021 (HealthDay News) — As U.S. health officials prepare to authorize the Pfizer COVID-19 vaccine for emergency use in younger children, a new poll shows that less than a third of parents would get their child vaccinated as soon as the shots are approved.
Read Full Text
U.S. Likely to Achieve July 4 COVID-19 Vaccination Target, but Challenges Remain
FRIDAY, May 7, 2021 (HealthDay News) — It is likely that the United States will achieve President Joe Biden’s target of having at least one dose of a COVID-19 vaccine into the arms of 70 percent of adults by July 4, but there could be challenges later in the year.
Read Full Text
Response to COVID-19 Vaccine Positive in Patients With IBD
FRIDAY, May 7, 2021 (HealthDay News) — Inflammatory bowel disease patients taking biologics achieved a positive antibody response to both the Moderna and Pfizer COVID-19 vaccines, according to research published online April 19 in Gastroenterology.
Read Full Text
Vaccination, NPI Compliance Needed to Prevent COVID-19 Surges
THURSDAY, May 6, 2021 (HealthDay News) — To prevent surges in COVID-19 cases, hospitalizations, and deaths, high vaccination rates and compliance with nonpharmaceutical interventions are needed, according to research published in the May 5 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Read Full Text
Two Doses of BNT162b2 SARS-CoV-2 Vaccine Highly Effective
THURSDAY, May 6, 2021 (HealthDay News) — Two doses of BNT162b2 are highly effective for preventing symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 infections and other outcomes, according to a study published online May 5 in The Lancet.
Read Full Text
Pfizer to Seek Approval in Fall for COVID-19 Vaccine Use in Children Aged 2 to 11
THURSDAY, May 6, 2021 (HealthDay News) — Emergency use authorization for the Pfizer COVID-19 vaccine to be given to children ages 2 to 11 years could be sought from the U.S. Food and Drug Administration by September, the company said Tuesday.
Read Full Text
Biden Administration to Back Lifting of COVID-19 Vaccine Patents
THURSDAY, May 6, 2021 (HealthDay News) — The Biden administration announced on Wednesday that it will support a controversial proposal to waive patent protections for COVID-19 vaccines.
Read Full Text
CDC Gives Cruise Ship Lines Guidelines for Simulated Voyages
THURSDAY, May 6, 2021 (HealthDay News) — Guidelines for cruise ship lines to conduct simulated voyages as a step toward resuming sailing in American waters were issued Tuesday by the U.S. Centers for Disease Control and Prevention.
Read Full Text
Psychological Well-Being Worse for Children During COVID-19
WEDNESDAY, May 5, 2021 (HealthDay News) — COVID-19 and the associated end of in-person instruction correlated with worse psychological well-being for children, according to a study published online April 29 in JAMA Network Open.
Read Full Text
Canada Approves Pfizer COVID-19 Vaccine for Children Ages 12 to 15
WEDNESDAY, May 5, 2021 (HealthDay News) — The Pfizer COVID-19 vaccine has been approved by Canadian health officials for use in children ages 12 to 15 years. It was already authorized for anyone 16 years and older.
Read Full Text
COVID-19-Associated Cancer Screening Deficit Quantified in U.S.
WEDNESDAY, May 5, 2021 (HealthDay News) — The absolute deficit in screening associated with the COVID-19 pandemic is estimated at 3.9, 3.8, and 1.6 million for breast, colorectal, and prostate cancers, respectively, across the U.S. population, according to a study published online April 29 in JAMA Oncology.
Read Full Text
COVID-19 Vaccine Hesitancy Found for 20 Percent on Hemodialysis
WEDNESDAY, May 5, 2021 (HealthDay News) — Twenty percent of patients on hemodialysis are hesitant to receive the COVID-19 vaccine, according to a study published online April 29 in the Journal of the American Society of Nephrology.
Read Full Text
Biden Sets New Goal of Vaccinating 70 Percent of Americans by July 4
WEDNESDAY, May 5, 2021 (HealthDay News) — As COVID-19 vaccination rates start to slow in the United States, President Joe Biden on Tuesday set a new goal to deliver at least one shot to 70 percent of adult Americans by July 4 while he tries to convince the hesitant to get inoculated.
Read Full Text
FDA Plans to Approve Pfizer Vaccine for Those Aged 12 Years and Older
TUESDAY, May 4, 2021 (HealthDay News) — The U.S. Food and Drug Administration plans to expand emergency use of the Pfizer COVID-19 vaccine by next week so that children as young as 12 years can be immunized.
Read Full Text
NYC, NJ, and Connecticut to Ease COVID-19 Capacity Restrictions
TUESDAY, May 4, 2021 (HealthDay News) — Shops, restaurants, theaters, and other businesses in New York, New Jersey, and Connecticut will be allowed to operate at full capacity starting May 19 as long as there is space for people to maintain 6 feet of social distance, the three states announced Monday.
Read Full Text
U.K. to Ease Lockdown Measures by June 21
TUESDAY, May 4, 2021 (HealthDay News) — Social distancing rules in the United Kingdom could be lifted by June 21, Prime Minister Boris Johnson said Monday.
Read Full Text
12 Cases of CVST Reported for Ad26.COV2.S Vaccine in the U.S.
TUESDAY, May 4, 2021 (HealthDay News) — Twelve cases of cerebral venous sinus thrombosis with thrombocytopenia have been reported following use of the Ad26.COV2.S COVID-19 vaccine (Janssen/Johnson & Johnson), which uses a human adenoviral vector, according to a study published online April 30 in the Journal of the American Medical Association.
Read Full Text
Child Abuse Hotline Volume Up During Pandemic
TUESDAY, May 4, 2021 (HealthDay News) — Calls and text messages to a child abuse hotline increased in the early days of the COVID-19 pandemic, according to a research letter published online May 3 in JAMA Pediatrics.
Read Full Text
Risk for Severe COVID-19 Increases With BMI Above 23
TUESDAY, May 4, 2021 (HealthDay News) — The risk for severe COVID-19 leading to hospital admission and death is increased at a body mass index of more than 23 kg/m2, according to a study published online April 28 in The Lancet Diabetes & Endocrinology.
Read Full Text
Anxiety-Related Adverse Event Clusters ID’d After Janssen Vaccine
MONDAY, May 3, 2021 (HealthDay News) — Syncope and other anxiety-related events occur more often after receipt of Janssen COVID-19 vaccines than influenza vaccination, according to research published in the April 30 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Read Full Text
Many in Japan Strongly Oppose Olympics
MONDAY, May 3, 2021 (HealthDay News) — The International Olympic Committee’s updated plans to hold the Summer Games in Japan have not quelled widespread criticism in the country about going ahead with the event.
Read Full Text
Effect of COVID-19 on Breast Cancer Treatment Examined
MONDAY, May 3, 2021 (HealthDay News) — More patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer have been treated with neoadjuvant endocrine therapy due to COVID-19, according to a study presented at the annual meeting of the American Society of Breast Surgeons, held virtually from April 29 to May 2.
Read Full Text
Risk Factors ID’d for COVID-19-Related Death in Diabetes
MONDAY, May 3, 2021 (HealthDay News) — For individuals with diabetes, the risk for COVID-19-related death is increased in association with male sex, older age, preexisting comorbidities, and use of insulin, according to a review published online April 28 in Diabetologia.
Read Full Text
Copyright © 2021 HealthDay. All rights reserved.
